346 related articles for article (PubMed ID: 25265257)
1. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy.
Lee JR; Srour M; Kim D; Hamdan FF; Lim SH; Brunel-Guitton C; Décarie JC; Rossignol E; Mitchell GA; Schreiber A; Moran R; Van Haren K; Richardson R; Nicolai J; Oberndorff KM; Wagner JD; Boycott KM; Rahikkala E; Junna N; Tyynismaa H; Cuppen I; Verbeek NE; Stumpel CT; Willemsen MA; de Munnik SA; Rouleau GA; Kim E; Kamsteeg EJ; Kleefstra T; Michaud JL
Hum Mutat; 2015 Jan; 36(1):69-78. PubMed ID: 25265257
[TBL] [Abstract][Full Text] [Related]
2. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia.
Ylikallio E; Kim D; Isohanni P; Auranen M; Kim E; Lönnqvist T; Tyynismaa H
Eur J Hum Genet; 2015 Oct; 23(10):1427-30. PubMed ID: 25585697
[TBL] [Abstract][Full Text] [Related]
3. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis.
Citterio A; Arnoldi A; Panzeri E; Merlini L; D'Angelo MG; Musumeci O; Toscano A; Bondi A; Martinuzzi A; Bresolin N; Bassi MT
J Neurol; 2015 Dec; 262(12):2684-90. PubMed ID: 26410750
[TBL] [Abstract][Full Text] [Related]
4. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.
Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG
J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427
[TBL] [Abstract][Full Text] [Related]
5. KIF1C mutations in two families with hereditary spastic paraparesis and cerebellar dysfunction.
Dor T; Cinnamon Y; Raymond L; Shaag A; Bouslam N; Bouhouche A; Gaussen M; Meyer V; Durr A; Brice A; Benomar A; Stevanin G; Schuelke M; Edvardson S
J Med Genet; 2014 Feb; 51(2):137-42. PubMed ID: 24319291
[TBL] [Abstract][Full Text] [Related]
6. De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy.
Esmaeeli Nieh S; Madou MR; Sirajuddin M; Fregeau B; McKnight D; Lexa K; Strober J; Spaeth C; Hallinan BE; Smaoui N; Pappas JG; Burrow TA; McDonald MT; Latibashvili M; Leshinsky-Silver E; Lev D; Blumkin L; Vale RD; Barkovich AJ; Sherr EH
Ann Clin Transl Neurol; 2015 Jun; 2(6):623-35. PubMed ID: 26125038
[TBL] [Abstract][Full Text] [Related]
7. KIF1A mutation in a patient with progressive neurodegeneration.
Okamoto N; Miya F; Tsunoda T; Yanagihara K; Kato M; Saitoh S; Yamasaki M; Kanemura Y; Kosaki K
J Hum Genet; 2014 Nov; 59(11):639-41. PubMed ID: 25253658
[TBL] [Abstract][Full Text] [Related]
8. De novo KIF1A mutations cause intellectual deficit, cerebellar atrophy, lower limb spasticity and visual disturbance.
Ohba C; Haginoya K; Osaka H; Kubota K; Ishiyama A; Hiraide T; Komaki H; Sasaki M; Miyatake S; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
J Hum Genet; 2015 Dec; 60(12):739-42. PubMed ID: 26354034
[TBL] [Abstract][Full Text] [Related]
9. A de novo dominant mutation in KIF1A associated with axonal neuropathy, spasticity and autism spectrum disorder.
Tomaselli PJ; Rossor AM; Horga A; Laura M; Blake JC; Houlden H; Reilly MM
J Peripher Nerv Syst; 2017 Dec; 22(4):460-463. PubMed ID: 28834584
[TBL] [Abstract][Full Text] [Related]
10. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia.
Pennings M; Schouten MI; van Gaalen J; Meijer RPP; de Bot ST; Kriek M; Saris CGJ; van den Berg LH; van Es MA; Zuidgeest DMH; Elting MW; van de Kamp JM; van Spaendonck-Zwarts KY; Die-Smulders C; Brilstra EH; Verschuuren CC; de Vries BBA; Bruijn J; Sofou K; Duijkers FA; Jaeger B; Schieving JH; van de Warrenburg BP; Kamsteeg EJ
Eur J Hum Genet; 2020 Jan; 28(1):40-49. PubMed ID: 31488895
[TBL] [Abstract][Full Text] [Related]
11. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene.
Cheon CK; Lim SH; Kim YM; Kim D; Lee NY; Yoon TS; Kim NS; Kim E; Lee JR
Sci Rep; 2017 Oct; 7(1):12527. PubMed ID: 28970574
[TBL] [Abstract][Full Text] [Related]
12. A Novel de novo KIF1A Mutation in a Patient with Autism, Hyperactivity, Epilepsy, Sensory Disturbance, and Spastic Paraplegia.
Kurihara M; Ishiura H; Bannai T; Mitsui J; Yoshimura J; Morishita S; Hayashi T; Shimizu J; Toda T; Tsuji S
Intern Med; 2020 Mar; 59(6):839-842. PubMed ID: 31813911
[TBL] [Abstract][Full Text] [Related]
13. De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome.
Langlois S; Tarailo-Graovac M; Sayson B; Drögemöller B; Swenerton A; Ross CJ; Wasserman WW; van Karnebeek CD
Eur J Hum Genet; 2016 Jun; 24(6):949-53. PubMed ID: 26486474
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic shock and encephalopathy syndrome in a patient with a de novo heterozygous variant in KIF1A.
Isobe K; Ieda D; Miya F; Miyachi R; Otsuji S; Asai M; Tsunoda T; Kosaki K; Hattori A; Saitoh S; Mizuno M
Brain Dev; 2022 Mar; 44(3):249-253. PubMed ID: 34916088
[TBL] [Abstract][Full Text] [Related]
15. KIF1A-related disorders in children: A wide spectrum of central and peripheral nervous system involvement.
Nemani T; Steel D; Kaliakatsos M; DeVile C; Ververi A; Scott R; Getov S; Sudhakar S; Male A; Mankad K; ; Muntoni F; Reilly MM; Kurian MA; Carr L; Munot P
J Peripher Nerv Syst; 2020 Jun; 25(2):117-124. PubMed ID: 32096284
[TBL] [Abstract][Full Text] [Related]
16. The novel
Yoshikawa K; Kuwahara M; Saigoh K; Ishiura H; Yamagishi Y; Hamano Y; Samukawa M; Suzuki H; Hirano M; Mitsui Y; Tsuji S; Kusunoki S
eNeurologicalSci; 2019 Mar; 14():34-37. PubMed ID: 30582020
[TBL] [Abstract][Full Text] [Related]
17. Disease-associated mutations hyperactivate KIF1A motility and anterograde axonal transport of synaptic vesicle precursors.
Chiba K; Takahashi H; Chen M; Obinata H; Arai S; Hashimoto K; Oda T; McKenney RJ; Niwa S
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18429-18434. PubMed ID: 31455732
[TBL] [Abstract][Full Text] [Related]
18. The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome.
Aguilera C; Hümmer S; Masanas M; Gabau E; Guitart M; Jeyaprakash AA; Segura MF; Santamaria A; Ruiz A
Front Neurosci; 2021; 15():618098. PubMed ID: 34121983
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous
Nicita F; Ginevrino M; Travaglini L; D'Arrigo S; Zorzi G; Borgatti R; Terrone G; Catteruccia M; Vasco G; Brankovic V; Siliquini S; Romano S; Veredice C; Pedemonte M; Armando M; Lettori D; Stregapede F; Bosco L; Sferra A; Tessarollo V; Romaniello R; Ristori G; Bertini E; Valente EM; Zanni G
J Med Genet; 2021 Jul; 58(7):475-483. PubMed ID: 32737135
[TBL] [Abstract][Full Text] [Related]
20. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2.
Rivière JB; Ramalingam S; Lavastre V; Shekarabi M; Holbert S; Lafontaine J; Srour M; Merner N; Rochefort D; Hince P; Gaudet R; Mes-Masson AM; Baets J; Houlden H; Brais B; Nicholson GA; Van Esch H; Nafissi S; De Jonghe P; Reilly MM; Timmerman V; Dion PA; Rouleau GA
Am J Hum Genet; 2011 Aug; 89(2):219-30. PubMed ID: 21820098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
